Eli Lilly is suing pharmacies and peptide vendors over sale of its next big weight-loss drug: retatrutide

Read full story on MarketWatch
Share
Eli Lilly is suing pharmacies and peptide vendors over sale of its next big weight-loss drug: retatrutide
AI disclosure

Summary

Some Americans have turned to medical spas and pharmacies that sell peptides for health and wellness benefits for access to compounded versions of retatrutide.

Original reporting

Open original source
Read full article on MarketWatch

Get the AFBytes Brief

Major stories, AI-assisted analysis, and what to watch next. Free, monthly, unsubscribe anytime.